Efficacy of passive transfer of immunity in young calves is commonly assessed using total serum protein (STP) or serum immunoglobulin G (IgG) concentration tested within the first few days of life. To our knowledge, no research has measured changes in these concentrations over this period to establish an appropriate age range for testing. The aim of this study was to monitor changes in STP and serum IgG concentrations from birth until 10 d of age to provide a basis for recommendations for when passive transfer of immunity in dairy calves can be measured. Concentrations of STP and IgG of 12 calves were measured at 11 time points: at approximately 30 min before colostrum feeding, at 24 h after colostrum feeding, and daily from d 2 to 10 of age. Mean (± standard deviation) STP and IgG concentrations were 4.61 ± 0.3 g/dL and 0.6 ± 0.6 mg/mL at birth, 5.83 ± 0.73 g/dL and 22.2 ± 9.6 mg/mL at 24 h after colostrum feeding, and 5.78 ± 0.52 g/dL and 16.1 ± 7.3 mg/mL at d 10 of age, respectively. The IgG concentration declined over subsequent days relative to IgG measured at 24 h at a rate of approximately 0.69 mg/mL per day, declining by 27.6 ± 6.2% (mean ± SD) on d 10. The concentration of STP did not decrease over time. Concentrations of IgG at 24 h after colostrum feeding were highly correlated with each of the measures of IgG over the 10-d period (r ≥0.97). These correlations were supported by the Bland-Altman plots of agreement between the 24-h sample and subsequent samples. Compared with the reference value at 24 h, STP concentrations were highly correlated on d 2 and 3 (r ≥0.98), highly correlated but variable from d 4 to 9 (r ≥0.88), and lower at d 10 (r = 0.76). These results indicate that calves may be reliably tested for passive transfer of immunity using IgG or STP concentrations up to 9 d of age.
Danish veterinarians’ treatment approach and use of antibiotics for clinical mastitis were investigated through a web-based questionnaire. The objective of the study was to describe and evaluate how the clinical mastitis treatment practice in Danish dairy herds corresponds to evidence from the literature and legislative requirements, in order to suggest directions for improvements and approaches encouraging the prudent use of antibiotics. In total, 174 veterinarians working with cattle received the questionnaire and 85 (48.9%) completed it. Their answers suggested that the Danish treatment approach for clinical mastitis generally relies on combined systemic and intramammary antibiotic administration (92% would use this often or always) and almost always includes supportive treatment with nonsteroidal anti-inflammatory drugs (99% would use it often or always in combination with antibiotic therapy). While collecting milk samples in order to target treatment towards pathogens is a priority in the legislation and for veterinarians, the direct application seems hindered due to the waiting time with the currently used analysis practice. Consequently, 91% reported that they would start treatment immediately after clinical examination often or always. The results of this investigation show that there is a potential for improvement in targeting treatments towards the causative pathogen by encouraging methods that allow for a more rapid reliable pathogen determination. When this issue has been addressed, the available evidence on the best treatment practice of Gram-negative-caused mastitis cases can be applied properly, reducing the volume of antibiotic treatments with limited expected effect. Additionally, investigating the potential of reducing combined administration to only intramammary treatment in Gram-positive cases could be a further step towards a more prudent antibiotic strategy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.